Skip to main content

Theralase Technologies: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (TLT)

AI-generated - The Globe and Mail - Mon May 19, 2025

Theralase Technologies is now ranked among the top 10 undervalued stocks in the Medical Devices & Instruments industry on the Toronto Stock Exchange or TSX Venture Exchange.

  • A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
  • Valuation methodology provided by Stockcalc (see below)

Medical Devices & Instruments: Companies that develop, manufacture, and market medical and surgical equipment and machinery, including orthopedic products, respiratory care equipment, x-ray equipment, laser systems, implants, pacemakers, and other major medical machines and apparatus.

Stocks in this category are held primarily for capital appreciation.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
EVMTEvome Medical0.010.010.01 (132.1%)3628310.50.00.0
PRNProfound Medical6.6310.273.64 (55.0%)11776199.20.00.0
THRMTherma Bright0.010.020.01 (48.9%)13672646.70.00.0
PINKPerimeter Medical Imaging0.430.540.11 (24.7%)5565031.10.00.0
VPTVentriPoint Diagnostics0.130.150.02 (16.6%)11054319.80.00.0
NGMDNuGen Medical Devices0.070.080.01 (9.3%)19181315.00.00.0
ZCTZero Candida Technologies0.330.340.01 (4.0%)7386.40.00.0
TLTTheralase Technologies0.170.180.00 (2.1%)5624442.00.00.0
FREQFrequency Exchange0.160.160.00 (2.0%)5427.10.00.0

All data provided as of May 19, 2025.
The list is sorted by stocks with the greatest percentage difference between valuation and price.

Theralase Technologies

Theralase Technologies Inc brings CLT to patients and personalized ACT to patients based on individual tissue characteristics. It is two separate reportable operating divisions; the Drug Division and the Device Division. The Drug Division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs), and activates them with proprietary and patent-pending laser technology to destroy specifically targeted cancers, bacteria and viruses.

Theralase Technologies is listed under TLT on the TSX Venture Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.

Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:

  • Discounted Cash Flow (DCF)
  • Price & Other Comparables
  • Multiples
  • Adjusted Book Value (ABV)
  • Analyst Consensus

Artificial Intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.